TMCI

Treace Medical Concepts, Inc.

• TipRanks·03/03 00:10

  Treace Medical Earnings Call Balances Progress and Pressure

• Dow Jones·03/02 20:41

  Treace Medical Concepts Price Target Cut to $7.00/Share From $7.50 by Lake Street

• Dow Jones·03/02 20:41

  Treace Medical Concepts Is Maintained at Buy by Lake Street

• TipRanks·03/02 14:26

  Treace Medical price target lowered to $2 from $3 at Truist

• TipRanks·03/02 14:12

  Treace Medical price target lowered to $2.25 from $2.50 at UBS

• TipRanks·03/02 13:59

  Treace Medical price target lowered to $7 from $7.50 at Lake Street

• TipRanks·03/02 13:06

  Truist Financial Sticks to Their Hold Rating for Treace Medical Concepts (TMCI)

• TipRanks·03/02 13:00

  Analysts Are Neutral on Top Healthcare Stocks: Amgen (AMGN), Treace Medical Concepts (TMCI)

• TipRanks·03/02 12:45

  Stifel Nicolaus Sticks to Its Hold Rating for Treace Medical Concepts (TMCI)

• Seeking Alpha·02/27 19:58

  Treace Medical signals 2026 revenue target of $200M–$212M while expanding comprehensive bunion solutions

• Seeking Alpha·02/27 12:28

  Treace Medical Concepts GAAP EPS of -$0.15 in-line, revenue of $62.5M beats by $0.63M

• Reuters·02/27 12:13

  Treace Medical Q4 revenue beats estimates; sees likely revenue drop in 2026

• TipRanks·02/27 12:12

  Treace Medical reports Q4 EPS (15c), consensus (15c)

• TipRanks·02/27 12:12

  Treace Medical sees FY26 revenue $200M-$212M, consensus $210.31M

• Dow Jones·02/27 12:06

  *Treace Medical Concepts Sees 2026 Rev $200M-$212M >TMCI